What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...

Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using ...

Research at City of Hope reveals how common white button mushrooms might enhance prostate cancer treatment through surprising ...

Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood -- known as the tertiary lymphoid structure -- where they become ...

John Ryan, a U.S. Navy veteran, beat cancer through nearly a decade of experimental immunotherapy treatment. The vet shared ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.

New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.

The Global Cancer Immunotherapy Market achieved a valuation of $121.2 Billion in 2023 and is anticipated to exceed $245.37 ...

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...